Skip to content

menu

Home About Services Contact
Keller and Heckman LLP logo
Keller and Heckman LLP logo

The Daily Intake

Legal and Regulatory updates for the food and supplement industry

cannabidiol

Subscribe to cannabidiol via RSS

FDA and FTC Issue Six Warning Letters for Delta-8 THC Copycat Snacks

Posted on July 10, 2023
  • Delta-8 Tetrahydrocannabinol (Delta-8 THC) is an isomer of Delta-9 THC, the intoxicating component of certain cannabis plants.  It is naturally occurring at very low levels in hemp and can be
… Continue Reading FDA and FTC Issue Six Warning Letters for Delta-8 THC Copycat Snacks

FDA Webinar Reiterates a New Regulatory Pathway Created by Federal Legislation is Required for CBD

Posted on June 5, 2023
  • A high-level internal working group that FDA convened to explore potential regulatory pathways for cannabidiol (CBD) products announced by way of a January 26, 2023 statement that existing regulatory pathways
… Continue Reading FDA Webinar Reiterates a New Regulatory Pathway Created by Federal Legislation is Required for CBD

Congress Edges Toward Regulation of Cannabis

Posted on April 15, 2022
  • This week, a bipartisan group of House members moved forward with a proposal to federally regulate cannabis similarly to the regulation of alcohol.  Written by Reps. Dave Joyce, R-OH, Hakeem

…
Continue Reading Congress Edges Toward Regulation of Cannabis

California Passes Hemp Bill into Law

Posted on October 12, 2021
  • On October 6, 2021, California Governor Gavin Newsom signed AB 45 into law, which allows for the inclusion of hemp and cannabinoids (e.g., CBD), extracts, or derivatives of hemp in

…
Continue Reading California Passes Hemp Bill into Law

Senators Unveil Draft Bill with Pathway for CBD

Posted on July 16, 2021
  • Senators Chuck Schumer (D-NY), Cory Booker (D-NJ), and Ron Wyden (D-OR) unveiled a lengthy discussion draft titled the Cannabis Administration and Opportunity Act on July 14. The draft language is

…
Continue Reading Senators Unveil Draft Bill with Pathway for CBD

CBD Suit Stayed Pending Further Action from FDA or Congress

Posted on March 9, 2021
  • On March 3, 2021, the U.S. District Court for the Central District of California invoked the primary jurisdiction doctrine to stay a consumer class action asserting various causes of action

…
Continue Reading CBD Suit Stayed Pending Further Action from FDA or Congress

Stay Connected

RSS LinkedIn Twitter

Blog Authors Show/Hide

  • Codi Coulter
  • Keller and Heckman LLP
  • Amber Grover
  • Jillian Guernsey
  • Lauren Haas
  • Kaitlyn Johnson
  • David Joy
  • Richard F. Mann
  • Evangelia C. Pelonis
  • Nicholas S. Prust
  • Frederick A. Stearns

Archives

Recent Updates

  • Texas Launches Another Investigation into Healthy Claims in Cereals
  • FDA and HHS Announce Next Steps in “Operation Stork Speed”
  • FDA and NIH Launch Joint Nutrition Regulatory Science Program
  • FDA Approves Three New Natural Food Colors
  • FDA Extends Comment Period for Front-of-Package Nutrition Labeling Rule

The Daily Intake

Keller and Heckman LLP
Boulder|Brussels|San Francisco|Shanghai|Washington, DC

To join our mailing list, click here.

RSS LinkedIn Twitter
DisclaimerPrivacy Policy

About our Firm

Keller and Heckman, founded in 1962, has a broad practice in the areas of regulatory law, public policy, and litigation, serving both domestic and international clients. Our firm is a pioneer in the use of interdisciplinary approaches to problem-solving. Since 1971, we have had an in-house scientific staff that works closely with the firm’s attorneys on matters of technical complexity. Many of our attorneys also have government experience and expertise in multiple areas of the law.

Read More…
Copyright © 2025, Keller and Heckman LLP. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo